{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:23:48Z","timestamp":1787736228908,"version":"build-2784847793"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-026-01774-9","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:03:10Z","timestamp":1787734990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineered autophagy receptors administered with extracellular vesicles eliminate pathological Tau and TDP-43"],"prefix":"10.1038","author":[{"given":"Huishan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Savard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Manser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-1300","authenticated-orcid":false,"given":"Kallol","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime W. C.","family":"Rousseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Julien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9305-8898","authenticated-orcid":false,"given":"Derrick","family":"Gibbings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"1774_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","volume":"12","author":"K Iqbal","year":"2016","unstructured":"Iqbal, K., Liu, F. & Gong, C. X. Tau and neurodegenerative disease: the story so far. Nat. Rev. Neurol. 12, 15\u201327 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"1774_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini, M. G. & Goedert, M. Tau pathology and neurodegeneration. Lancet Neurol. 12, 609\u2013622 (2013).","journal-title":"Lancet Neurol."},{"key":"1774_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1750-1326-9-29","volume":"9","author":"P Lei","year":"2014","unstructured":"Lei, P. et al. Motor and cognitive deficits in aged tau knockout mice in two background strains. Mol. Neurodegener. 9, 29 (2014).","journal-title":"Mol. Neurodegener."},{"key":"1774_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"1774_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IRA Mackenzie","year":"2007","unstructured":"Mackenzie, I. R. A. et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427\u2013434 (2007).","journal-title":"Ann. Neurol."},{"key":"1774_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor, J. P., Brown, R. H. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197\u2013206 (2016).","journal-title":"Nature"},{"key":"1774_CR7","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1073\/pnas.0912417107","volume":"107","author":"H Wils","year":"2010","unstructured":"Wils, H. et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 107, 3858\u20133863 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1774_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00401-015-1486-0","volume":"130","author":"YD Ke","year":"2015","unstructured":"Ke, Y. D. et al. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathol. 130, 661\u2013678 (2015).","journal-title":"Acta Neuropathol."},{"key":"1774_CR9","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/brain\/awr159","volume":"134","author":"V Swarup","year":"2011","unstructured":"Swarup, V. et al. Pathological hallmarks of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 134, 2610\u20132626 (2011).","journal-title":"Brain"},{"key":"1774_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-010-0659-0","volume":"119","author":"BC Kraemer","year":"2010","unstructured":"Kraemer, B. C. et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 119, 409\u2013419 (2010).","journal-title":"Acta Neuropathol."},{"key":"1774_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.it.2017.07.005","volume":"38","author":"DA Rhodes","year":"2017","unstructured":"Rhodes, D. A. & Isenberg, D. A. TRIM21 and the function of antibodies inside cells. Trends Immunol. 38, 916\u2013926 (2017).","journal-title":"Trends Immunol."},{"key":"1774_CR12","doi-asserted-by":"publisher","unstructured":"James, L. C., Keeble, A. H., Khan, Z., Rhodes, D. A. & Trowsdale, J. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.0609174104 (2007).","DOI":"10.1073\/pnas.0609174104"},{"key":"1774_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41594-021-00560-2","volume":"28","author":"J Zeng","year":"2021","unstructured":"Zeng, J. et al. Target-induced clustering activates Trim-Away of pathogens and proteins. Nat. Struct. Mol. Biol. 28, 278\u2013289 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1774_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1073\/pnas.1607215114","volume":"114","author":"WA McEwan","year":"2017","unstructured":"McEwan, W. A. et al. Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation. Proc. Natl Acad. Sci. USA 114, 574\u2013579 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1774_CR15","doi-asserted-by":"publisher","first-page":"e45457","DOI":"10.7554\/eLife.45457","volume":"8","author":"MC Silva","year":"2019","unstructured":"Silva, M. C. et al. Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models. eLife 8, e45457 (2019).","journal-title":"eLife"},{"key":"1774_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2183\/pjab.85.12","volume":"85","author":"K Tanaka","year":"2009","unstructured":"Tanaka, K. The proteasome: overview of structure and functions. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 85, 12\u201336 (2009).","journal-title":"Proc. Jpn Acad. Ser. B Phys. Biol. Sci."},{"key":"1774_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2017.08.009","volume":"171","author":"FJB B\u00e4uerlein","year":"2017","unstructured":"B\u00e4uerlein, F. J. B. et al. In situ architecture and cellular interactions of PolyQ inclusions. Cell 171, 179\u2013187.e10 (2017).","journal-title":"Cell"},{"key":"1774_CR18","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cell.2017.12.030","volume":"172","author":"Q Guo","year":"2018","unstructured":"Guo, Q. et al. In situ structure of neuronal C9ORF72 poly-GA aggregates reveals proteasome recruitment. Cell 172, 696\u2013705.e12 (2018).","journal-title":"Cell"},{"key":"1774_CR19","doi-asserted-by":"crossref","unstructured":"Wolozin, B. & Ivanov, P. Stress granules and neurodegeneration. Nat. Rev. Neurosci. 20, 649\u2013666 (2019).","DOI":"10.1038\/s41583-019-0222-5"},{"key":"1774_CR20","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"key":"1774_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00401-008-0408-9","volume":"116","author":"WL Lin","year":"2008","unstructured":"Lin, W. L. & Dickson, D. W. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol. 116, 205\u2013213 (2008).","journal-title":"Acta Neuropathol."},{"key":"1774_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22108-0","volume":"12","author":"VA Trinkaus","year":"2021","unstructured":"Trinkaus, V. A. et al. In situ architecture of neuronal \u03b1-Synuclein inclusions. Nat. Commun. 12, 2110 (2021).","journal-title":"Nat. Commun."},{"key":"1774_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","volume":"580","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. Novel tau filament fold in corticobasal degeneration. Nature 580, 283\u2013287 (2020).","journal-title":"Nature"},{"key":"1774_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.devcel.2017.11.018","volume":"43","author":"H Guo","year":"2017","unstructured":"Guo, H. et al. Atg5 disassociates the V1V0-ATPase to promote exosome production and tumor metastasis independent of canonical macroautophagy. Dev. Cell 43, 716\u2013730.e7 (2017).","journal-title":"Dev. Cell"},{"key":"1774_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41556-019-0450-y","volume":"22","author":"AM Leidal","year":"2020","unstructured":"Leidal, A. M. et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat. Cell Biol. 22, 187\u2013199 (2020).","journal-title":"Nat. Cell Biol."},{"key":"1774_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nbt0111-3","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 3\u20134 (2011).","journal-title":"Nat. Biotechnol."},{"key":"1774_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","volume":"172","author":"SAA Kooijmans","year":"2013","unstructured":"Kooijmans, S. A. A. et al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J. Control. Release 172, 229\u2013238 (2013).","journal-title":"J. Control. Release"},{"key":"1774_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","volume":"23","author":"G van Niel","year":"2022","unstructured":"van Niel, G. et al. Challenges and directions in studying cell\u2013cell communication by extracellular vesicles. Nat. Rev. Mol. Cell Biol. 23, 369\u2013382 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1774_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41551-019-0502-4","volume":"4","author":"R Reshke","year":"2020","unstructured":"Reshke, R. et al. Reduction of the therapeutic dose of silencing RNA by packaging it in extracellular vesicles via a pre-microRNA backbone. Nat. Biomed. Eng 4, 52\u201368 (2020).","journal-title":"Nat. Biomed. Eng"},{"key":"1774_CR30","doi-asserted-by":"publisher","first-page":"100424","DOI":"10.1016\/j.celbio.2026.100424","volume":"2","author":"K Dutta","year":"2026","unstructured":"Dutta, K. et al. Screening extracellular vesicle-producing cells enables delivery of silencing RNAs to the kidney and brain in small and large animals. Cell Biomater. 2, 100424 (2026).","journal-title":"Cell Biomater."},{"key":"1774_CR31","doi-asserted-by":"publisher","first-page":"e12220","DOI":"10.1002\/jev2.12220","volume":"11","author":"J McCann","year":"2022","unstructured":"McCann, J. et al. Contaminating transfection complexes can masquerade as small extracellular vesicles and impair their delivery of RNA. J. Extracell. Vesicles 11, e12220 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"1774_CR32","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1021\/acs.nanolett.1c00094","volume":"21","author":"DE Murphy","year":"2021","unstructured":"Murphy, D. E. et al. Natural or synthetic RNA delivery: a stoichiometric comparison of extracellular vesicles and synthetic nanoparticles. Nano Lett. 21, 1888\u20131895 (2021).","journal-title":"Nano Lett."},{"key":"1774_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014556","volume":"85","author":"CF Bento","year":"2016","unstructured":"Bento, C. F. et al. Mammalian autophagy: how does it work? Annu. Rev. Biochem. 85, 685\u2013713 (2016).","journal-title":"Annu. Rev. Biochem."},{"key":"1774_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ncb2012","volume":"12","author":"S Geisler","year":"2010","unstructured":"Geisler, S. et al. PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1. Nat. Cell Biol. 12, 119\u2013131 (2010).","journal-title":"Nat. Cell Biol."},{"key":"1774_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou, M. et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309\u2013314 (2015).","journal-title":"Nature"},{"key":"1774_CR36","first-page":"939","volume":"126","author":"E Deosaran","year":"2013","unstructured":"Deosaran, E. et al. NBR1 acts as an autophagy receptor for peroxisomes. J. Cell Sci. 126, 939\u2013952 (2013).","journal-title":"J. Cell Sci."},{"key":"1774_CR37","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1080\/15548627.2021.1886839","volume":"17","author":"S Robichaud","year":"2021","unstructured":"Robichaud, S. et al. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells. Autophagy 17, 3671\u20133689 (2021).","journal-title":"Autophagy"},{"key":"1774_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nature10744","volume":"482","author":"TLM Thurston","year":"2012","unstructured":"Thurston, T. L. M., Wandel, M. P., Von Muhlinen, N., Foeglein, \u00c1 & Randow, F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482, 414\u2013418 (2012).","journal-title":"Nature"},{"key":"1774_CR39","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","volume":"93","author":"FM Menzies","year":"2017","unstructured":"Menzies, F. M. et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93, 1015\u20131034 (2017).","journal-title":"Neuron"},{"key":"1774_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6276","volume":"5","author":"H Guo","year":"2014","unstructured":"Guo, H. et al. Autophagy supports genomic stability by degrading retrotransposon RNA. Nat. Commun. 5, 5276 (2014).","journal-title":"Nat. Commun."},{"key":"1774_CR41","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.cell.2013.05.037","volume":"153","author":"JR Buchan","year":"2013","unstructured":"Buchan, J. R., Kolaitis, R.-M., Taylor, J. P. & Parker, R. Eukaryotic stress granules are cleared by autophagy and Cdc48\/VCP function. Cell 153, 1461\u20131474 (2013).","journal-title":"Cell"},{"key":"1774_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jmb.2019.07.016","volume":"432","author":"T Johansen","year":"2020","unstructured":"Johansen, T. & Lamark, T. Selective autophagy: ATG8 family proteins, LIR motifs and cargo receptors. J. Mol. Biol. 432, 80\u2013103 (2020).","journal-title":"J. Mol. Biol."},{"key":"1774_CR43","doi-asserted-by":"publisher","first-page":"e62459","DOI":"10.1371\/journal.pone.0062459","volume":"8","author":"S Ozcelik","year":"2013","unstructured":"Ozcelik, S. et al. Rapamycin attenuates the progression of Tau pathology in P301S Tau transgenic mice. PLoS ONE 8, e62459 (2013).","journal-title":"PLoS ONE"},{"key":"1774_CR44","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/brain\/aws143","volume":"135","author":"V Schaeffer","year":"2012","unstructured":"Schaeffer, V. et al. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain 135, 2169\u20132177 (2012).","journal-title":"Brain"},{"key":"1774_CR45","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nchembio.1563","volume":"10","author":"SJ Barmada","year":"2014","unstructured":"Barmada, S. J. et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 10, 677\u2013685 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"1774_CR46","doi-asserted-by":"publisher","first-page":"15024","DOI":"10.1073\/pnas.1206362109","volume":"109","author":"IF Wang","year":"2012","unstructured":"Wang, I. F. et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl Acad. Sci. USA 109, 15024\u201315029 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1774_CR47","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","volume":"76","author":"D Takahashi","year":"2019","unstructured":"Takahashi, D. et al. AUTACs: cargo-specific degraders using selective autophagy. Mol. Cell 76, 797\u2013810.e10 (2019).","journal-title":"Mol. Cell"},{"key":"1774_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28520-4","volume":"13","author":"CH Ji","year":"2022","unstructured":"Ji, C. H. et al. The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system. Nat. Commun. 13, 904 (2022).","journal-title":"Nat. Commun."},{"key":"1774_CR49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nbt.1608","volume":"28","author":"PO Bauer","year":"2010","unstructured":"Bauer, P. O. et al. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat. Biotechnol. 28, 256\u2013263 (2010).","journal-title":"Nat. Biotechnol."},{"key":"1774_CR50","doi-asserted-by":"publisher","first-page":"23939","DOI":"10.1021\/jacs.3c05199","volume":"145","author":"Z Jiang","year":"2023","unstructured":"Jiang, Z., Arkin, M. R. & Kuo, Y. H. Autophagy receptor-inspired antibody-fusion proteins for targeted intracellular degradation. J. Am. Chem. Soc. 145, 23939\u201323947 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"1774_CR51","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/JCI123931","volume":"129","author":"S Pozzi","year":"2019","unstructured":"Pozzi, S. et al. Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology. J. Clin. Invest. 129, 1581\u20131595 (2019).","journal-title":"J. Clin. Invest."},{"key":"1774_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2016.09.019","volume":"243","author":"T Li","year":"2016","unstructured":"Li, T. et al. Camelid single-domain antibodies: a versatile tool for in vivo imaging of extracellular and intracellular brain targets. J. Control. Release 243, 1\u201310 (2016).","journal-title":"J. Control. Release"},{"key":"1774_CR53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/auto.19496","volume":"8","author":"D Klionsky","year":"2016","unstructured":"Klionsky, D. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445\u2013544 (2016).","journal-title":"Autophagy"},{"key":"1774_CR54","doi-asserted-by":"publisher","first-page":"e13250","DOI":"10.1371\/journal.pone.0013250","volume":"5","author":"L Liu-Yesucevitz","year":"2010","unstructured":"Liu-Yesucevitz, L. et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS ONE 5, e13250 (2010).","journal-title":"PLoS ONE"},{"key":"1774_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.neuron.2019.02.038","volume":"102","author":"F Gasset-Rosa","year":"2019","unstructured":"Gasset-Rosa, F. et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339\u2013357.e7 (2019).","journal-title":"Neuron"},{"key":"1774_CR56","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1083\/jcb.201302044","volume":"201","author":"YR Li","year":"2013","unstructured":"Li, Y. R., King, O. D., Shorter, J. & Gitler, A. D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201, 361\u2013372 (2013).","journal-title":"J. Cell Biol."},{"key":"1774_CR57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neuron.2019.03.041","volume":"102","author":"B Wolozin","year":"2019","unstructured":"Wolozin, B. The evolution of phase-separated TDP-43 in stress. Neuron 102, 265\u2013267 (2019).","journal-title":"Neuron"},{"key":"1774_CR58","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1073\/pnas.91.12.5705","volume":"91","author":"JF Poduslo","year":"1994","unstructured":"Poduslo, J. F., Curran, G. L. & Berg, C. T. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc. Natl Acad. Sci. USA 91, 5705\u20135709 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1774_CR59","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13311-013-0187-4","volume":"10","author":"YJ Yu","year":"2013","unstructured":"Yu, Y. J. & Watts, R. J. Developing therapeutic antibodies for neurodegenerative disease. Neurotherapeutics 10, 459\u2013472 (2013).","journal-title":"Neurotherapeutics"},{"key":"1774_CR60","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrd4363","volume":"13","author":"S Mitragotri","year":"2014","unstructured":"Mitragotri, S., Burke, P. A. & Langer, R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat. Rev. Drug Discov. 13, 655\u2013672 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1774_CR61","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/ijms21124407","volume":"21","author":"WA Banks","year":"2020","unstructured":"Banks, W. A. et al. Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation. Int. J. Mol. Sci. 21, 4407 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1774_CR62","doi-asserted-by":"publisher","first-page":"111896","DOI":"10.1016\/j.celrep.2022.111896","volume":"42","author":"F Limone","year":"2023","unstructured":"Limone, F. et al. Efficient generation of lower induced motor neurons by coupling Ngn2 expression with developmental cues. Cell Rep. 42, 111896 (2023).","journal-title":"Cell Rep."},{"key":"1774_CR63","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","volume":"130","author":"AK Walker","year":"2015","unstructured":"Walker, A. K. et al. Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 130, 643\u2013660 (2015).","journal-title":"Acta Neuropathol."},{"key":"1774_CR64","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"BE Deverman","year":"2016","unstructured":"Deverman, B. E. et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat. Biotechnol. 34, 204\u2013209 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1774_CR65","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547, 185\u2013190 (2017).","journal-title":"Nature"},{"key":"1774_CR66","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-023-06788-w","volume":"625","author":"S L\u00f6vestam","year":"2023","unstructured":"L\u00f6vestam, S. et al. Disease-specific tau filaments assemble via polymorphic intermediates. Nature 625, 119\u2013125 (2023).","journal-title":"Nature"},{"key":"1774_CR67","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/nprot.2007.207","volume":"2","author":"GJ Brewer","year":"2007","unstructured":"Brewer, G. J. & Torricelli, J. R. Isolation and culture of adult neurons and neurospheres. Nat. Protoc. 2, 1490\u20131498 (2007).","journal-title":"Nat. Protoc."},{"key":"1774_CR68","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351 (2007).","journal-title":"Neuron"},{"key":"1774_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. The release and trans-synaptic transmission of Tau via exosomes. Mol. Neurodegener. 12, 5 (2017).","journal-title":"Mol. Neurodegener."},{"key":"1774_CR70","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai, H. et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584\u20131593 (2015).","journal-title":"Nat. Neurosci."},{"key":"1774_CR71","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ymthe.2021.01.020","volume":"29","author":"K Dooley","year":"2021","unstructured":"Dooley, K. et al. A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties. Mol. Ther. 29, 1729\u20131743 (2021).","journal-title":"Mol. Ther."},{"key":"1774_CR72","doi-asserted-by":"publisher","first-page":"eaag0481","DOI":"10.1126\/scitranslmed.aag0481","volume":"9","author":"SL DeVos","year":"2017","unstructured":"DeVos, S. L. et al. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci. Transl. Med. 9, eaag0481 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1774_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16984-1","volume":"11","author":"MC Silva","year":"2020","unstructured":"Silva, M. C. et al. Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons. Nat. Commun. 11, 3258 (2020).","journal-title":"Nat. Commun."},{"key":"1774_CR74","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.nucmedbio.2022.04.002","volume":"114\u2013115","author":"SR Meier","year":"2022","unstructured":"Meier, S. R., Sehlin, D. & Syv\u00e4nen, S. Passive and receptor mediated brain delivery of an anti-GFAP nanobody. Nucl. Med. Biol. 114\u2013115, 128\u2013134 (2022).","journal-title":"Nucl. Med. Biol."},{"key":"1774_CR75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Wu, K. M., Yang, L., Dong, Q. & Yu, J. T. Tauopathies: new perspectives and challenges. Mol. Neurodegener. 17, 28 (2022).","journal-title":"Mol. Neurodegener."},{"key":"1774_CR76","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy, A. et al. Tau PET imaging in neurodegenerative tauopathies\u2014still a challenge. Mol. Psychiatry 24, 1112\u20131134 (2019).","journal-title":"Mol. Psychiatry"},{"key":"1774_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10059-6","volume":"10","author":"M Wirth","year":"2019","unstructured":"Wirth, M. et al. Molecular determinants regulating selective binding of autophagy adapters and receptors to ATG8 proteins. Nat. Commun. 10, 2055 (2019).","journal-title":"Nat. Commun."},{"key":"1774_CR78","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/archneurol.2011.250","volume":"68","author":"F Fecto","year":"2011","unstructured":"Fecto, F. et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 68, 1440\u20131446 (2011).","journal-title":"Arch. Neurol."},{"key":"1774_CR79","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00401-015-1436-x","volume":"130","author":"C Pottier","year":"2015","unstructured":"Pottier, C. et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 130, 77\u201392 (2015).","journal-title":"Acta Neuropathol."},{"key":"1774_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mcn.2015.01.002","volume":"66","author":"V Majcher","year":"2015","unstructured":"Majcher, V., Goode, A., James, V. & Layfield, R. Autophagy receptor defects and ALS-FTLD. Mol. Cell. Neurosci. 66, 43\u201352 (2015).","journal-title":"Mol. Cell. Neurosci."},{"key":"1774_CR81","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2990.2007.00884.x","volume":"34","author":"E Kuusisto","year":"2008","unstructured":"Kuusisto, E., Kauppinen, T. & Alafuzoff, I. Use of p62\/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol. Appl. Neurobiol. 34, 169\u2013180 (2008).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1774_CR82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0002-9440(10)64369-6","volume":"160","author":"K Zatloukal","year":"2002","unstructured":"Zatloukal, K. et al. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160, 255\u2013263 (2002).","journal-title":"Am. J. Pathol."},{"key":"1774_CR83","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","volume":"110","author":"A Fleming","year":"2022","unstructured":"Fleming, A. et al. The different autophagy degradation pathways and neurodegeneration. Neuron 110, 935\u2013966 (2022).","journal-title":"Neuron"},{"key":"1774_CR84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-023-00630-7","volume":"18","author":"J Lee","year":"2023","unstructured":"Lee, J. et al. Targeted degradation of \u03b1-synuclein aggregates in Parkinson\u2019s disease using the AUTOTAC technology. Mol. Neurodegener. 18, 41 (2023).","journal-title":"Mol. Neurodegener."},{"key":"1774_CR85","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","volume":"575","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Allele-selective lowering of mutant HTT protein by HTT\u2013LC3 linker compounds. Nature 575, 203\u2013209 (2019).","journal-title":"Nature"},{"key":"1774_CR86","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1080\/15548627.2023.2234797","volume":"19","author":"L Mei","year":"2023","unstructured":"Mei, L. et al. Tethering ATG16L1 or LC3 induces targeted autophagic degradation of protein aggregates and mitochondria. Autophagy 19, 2997\u20133013 (2023).","journal-title":"Autophagy"},{"key":"1774_CR87","doi-asserted-by":"publisher","unstructured":"Farrell, K. & Jarome, T. J. Is PROTAC technology really a game changer for central nervous system drug discovery? Expert Opin. Drug Discov. 16, 833\u2013840 https:\/\/doi.org\/10.1080\/17460441.2021.1915979 (2021).","DOI":"10.1080\/17460441.2021.1915979"},{"key":"1774_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41421-018-0079-1","volume":"5","author":"X Sun","year":"2019","unstructured":"Sun, X. et al. A chemical approach for global protein knockdown from mice to non-human primates. Cell Discov. 5, 10 (2019).","journal-title":"Cell Discov."},{"key":"1774_CR89","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470\u20131476 (2008).","journal-title":"Nat. Cell Biol."},{"key":"1774_CR90","doi-asserted-by":"publisher","first-page":"1582237","DOI":"10.1080\/20013078.2019.1582237","volume":"8","author":"JB Simonsen","year":"2019","unstructured":"Simonsen, J. B. Pitfalls associated with lipophilic fluorophore staining of extracellular vesicles for uptake studies. J. Extracell. Vesicles 8, 1582237 (2019).","journal-title":"J. Extracell. Vesicles"},{"key":"1774_CR91","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/bs.mie.2020.09.002","volume":"645","author":"M Dehghani","year":"2020","unstructured":"Dehghani, M. & Gaborski, T. R. Fluorescent labeling of extracellular vesicles. Methods Enzymol. 645, 15\u201342 (2020).","journal-title":"Methods Enzymol."},{"key":"1774_CR92","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-020-00404-5","volume":"15","author":"GS Gibbons","year":"2020","unstructured":"Gibbons, G. S. et al. Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 15, 64 (2020).","journal-title":"Mol. Neurodegener."},{"key":"1774_CR93","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/acn3.176","volume":"2","author":"K Yanamandra","year":"2015","unstructured":"Yanamandra, K. et al. Anti-tau antibody reduces insoluble tau and decreases brain atrophy. Ann. Clin. Transl. Neurol. 2, 278\u2013288 (2015).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1774_CR94","doi-asserted-by":"publisher","first-page":"e19809","DOI":"10.7554\/eLife.19809","volume":"5","author":"MWC Rousseaux","year":"2016","unstructured":"Rousseaux, M. W. C. et al. TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau. eLife 5, e19809 (2016).","journal-title":"eLife"},{"key":"1774_CR95","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1074\/mcp.M700342-MCP200","volume":"7","author":"U Rothbauer","year":"2008","unstructured":"Rothbauer, U. et al. A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol. Cell. Proteomics 7, 282\u2013289 (2008).","journal-title":"Mol. Cell. Proteomics"},{"key":"1774_CR96","unstructured":"Fagret, D. et al. Anti-tau nanobodies. US patent US20190263898 https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=US251053269&tab=NATIONALBIBLIO&_cid=P12-KVBGG2-75242-1 (2019)."},{"key":"1774_CR97","first-page":"3.22.1","volume":"3","author":"C Th\u00e9ry","year":"2006","unstructured":"Th\u00e9ry, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 3, 3.22.1\u20133.22.29 (2006).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"1774_CR98","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker, L. A. et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544, 367\u2013371 (2017).","journal-title":"Nature"},{"key":"1774_CR99","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1083\/jcb.144.5.891","volume":"144","author":"S Desagher","year":"1999","unstructured":"Desagher, S. et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144, 891\u2013901 (1999).","journal-title":"J. Cell Biol."},{"key":"1774_CR100","doi-asserted-by":"publisher","first-page":"40877","DOI":"10.1074\/jbc.M306177200","volume":"278","author":"X Roucou","year":"2003","unstructured":"Roucou, X., Guo, Q., Zhang, Y., Goodyer, C. G. & LeBlanc, A. C. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J. Biol. Chem. 278, 40877\u201340881 (2003).","journal-title":"J. Biol. Chem."},{"key":"1774_CR101","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/978-1-61779-551-0_32","volume":"849","author":"C Julien","year":"2012","unstructured":"Julien, C., Bretteville, A. & Planel, E. Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies. Methods Mol. Biol. 849, 473\u2013491 (2012).","journal-title":"Methods Mol. Biol."},{"key":"1774_CR102","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-016-0100-9","volume":"11","author":"Y Xu","year":"2016","unstructured":"Xu, Y., Martini-Stoica, H. & Zheng, H. A seeding based cellular assay of tauopathy. Mol. Neurodegener. 11, 32 (2016).","journal-title":"Mol. Neurodegener."},{"key":"1774_CR103","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ncb2611","volume":"14","author":"D Gibbings","year":"2012","unstructured":"Gibbings, D. et al. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat. Cell Biol. 14, 1314\u20131321 (2012).","journal-title":"Nat. Cell Biol."},{"key":"1774_CR104","doi-asserted-by":"publisher","unstructured":"Gibbings, D. Source data for: engineered autophagy receptors administered with extracellular vesicles eliminate pathological Tau and TDP-43. figshare https:\/\/doi.org\/10.6084\/m9.figshare.32099401 (2026).","DOI":"10.6084\/m9.figshare.32099401"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01774-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01774-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01774-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:03:13Z","timestamp":1787734993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01774-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":104,"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01774-9","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.G. is an inventor on patents or provisional patents claiming the use of LC3-fusion proteins as autophagy-targeting therapeutics (US20240299362A1) and a provisional patent on types of extracellular vesicles as delivery vehicles for the central nervous system. J.-P.J. and S.P. are inventors on a patent claiming the single domain antibody targeting TDP-43 (US10202443B2). The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}